Genetic proxies for antihypertensive drugs and mental disorders: Mendelian randomization study in European and East Asian populations
Abstract Background Mental disorders are among the top causes of disease burden worldwide. Existing evidence regarding the repurposing of antihypertensives for mental disorders treatment is conflicting and cannot establish causation. Methods We used Mendelian randomization to assess the effects of a...
Main Authors: | Bohan Fan, Jie V. Zhao |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2024-01-01
|
Series: | BMC Medicine |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12916-023-03218-6 |
Similar Items
-
Genetically predicted hypertension, antihypertensive drugs, and risk of erectile dysfunction: a Mendelian randomization study
by: Cong Zhao, et al.
Published: (2023-06-01) -
Association between antihypertensive drugs and oral cancer: a drug target Mendelian randomization study
by: Junfeng Guo, et al.
Published: (2023-11-01) -
Hypertension, antihypertensive drugs, and age at onset of Huntington’s disease
by: Yahui Zhu, et al.
Published: (2023-05-01) -
Protective effect of antihypertensive drugs on the risk of Parkinson’s disease lacks causal evidence from mendelian randomization
by: Zheng Jiang, et al.
Published: (2023-02-01) -
Association of antihypertensive drugs with fracture and bone mineral density: A comprehensive drug-target Mendelian randomization study
by: Xin Huang, et al.
Published: (2023-03-01)